Moreover, TRIM28’s capacity to engage with the immune system, especially via its function in immune regulation and inflammation, emphasizes the possibility of using it as a therapeutic target in the tumor microenvironment in addition to cancer. This evidence concerns the gene TRIM28 and neoplasm.